A securities class action lawsuit against Pomdoctor Limited (NASDAQ: POM) has entered a critical phase, with investors required to take action by April 13, 2026, to participate in the litigation. Law firm Faruqi & Faruqi, LLP is investigating allegations that the company and its executives engaged in securities fraud through false statements and undisclosed promotional activities.
According to court filings, the complaint centers on claims that Pomdoctor orchestrated a fraudulent scheme involving coordinated social media misinformation campaigns, insider share dispositions, and artificially inflated trading volumes. The alleged misconduct came to light following a sharp market correction on December 11, 2025, when the company's stock price declined approximately 24%, closing at $0.38 per share compared to its opening price of $0.50.
Investors who purchased Pomdoctor securities during the relevant period and suffered losses may be eligible for compensation through the class action settlement process. Those seeking to establish lead plaintiff status or obtain additional information about the litigation are advised to contact legal counsel immediately, as the April 2026 deadline represents a firm cutoff for participation in the federal securities class action.